Stocktoria
STAAR SURGICAL CO STAA
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 1992-02-24
STAAR SURGICAL CO statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 76.2% | 76.3% | 78.4% | 93.3% | 77.5% |
| Operating margin | -38.3% | -4.0% | 8.7% | 18.3% | 14.5% |
| Net margin | -33.6% | -6.4% | 6.6% | 16.6% | 11.9% |
| FCF margin | -16.7% | -2.4% | -1.1% | 7.4% | 13.2% |
| Return on assets | -17.8% | -4.0% | 4.4% | 9.5% | 8.0% |
| Return on equity | -23.4% | -5.1% | 5.5% | 11.8% | 10.5% |
| Current ratio | 4.55 | 5.23 | 5.62 | 6.03 | 5.56 |
| Revenue growth | -23.7% | -2.6% | 34.7% | 3.9% | 41.0% |
Source: SEC EDGAR filings · CIK 0000718937 · as of 2026-01-02. Facts from filings plus Stocktoria's own computed scores — not investment advice.